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sTable 1. Longitudinal studies of neuropsychological functioning in first episode psychosis. Included are studies with or without a comparison groups 
with a follow-up durations of at least one year. 
 
Study N (Subjects) Length of 
follow-up 
Summary of findings 
Scottish Schizophrenia 
Research Group (1988)(1) 
28 FE patients  1 year Improvement on Raven’s Progressive Matrices, Block Design and Digit copying; No change 
on Vocabulary and Similarities  
Hoff et al. (1991)(2)  15 FE patients 
 
2 years Improvement on Executive, Concentration/Speed and Global scales 
Bilder et al. (1991)(3) 28 FE patients 1 year High stability of test scores overall; Improvement on tests of attentional, motor, and 
memory functions; Decline on Digit Span 
Sweeney et al. (1991)(4) 15 FE patients 1 year Improvement on psychomotor (Trails A and B, Digit Symbol and Finger Tapping), 
Judgment of Line Orientation and Rey AVLT tests. No change on Digit Span, Block Design, 
verbal fluency, verbal learning/recall and immediate/delayed visual memory. 
Nopoulos et al. (1994)(5) 35 FE patients 1 (n=17)/2 
(n=18) 
years 
No change on most neuropsychological scores; Improvement on Trails B, Stroop Colored 
Dots and Stroop Interference. 
Censits et al. (1997)(6) 30 FE patients  19 months Stable performance on all neuropsychological tests. 
Hoff et al. (1999)(7) 42 FE patients  




Patients showed no improvement on verbal memory and sensory-perceptual domains 
compared to controls and showed deterioration in verbal memory. 
Gold et al. (1999)(8) 21 FE patients 
33 recent onset patients 
5 years Improvement on performance IQ, full-scale IQ, letter-cancellation, logical memory free 
recall, WCST categories; Decline in finger tapping. 
Hofer et al. (2000)(9) 16 FE patients  1 year Normalization of neuropsychological performance over time. 
Purdon et al. (2000)(10) 55 FE patients 1 year Improvement or stability on all neuropsychological tests.   
Albus et al. (2002)(11) 50 FE patients 
50 healthy controls 
2 years Improvement in verbal learning; No change in semantic memory, visual-motor processing 
and attention, and abstraction/flexibility; Deterioration in visual memory. 
Townsend et al. (2002)(12) 83 FE patients 1 year Improvement on verbal and performance IQ, measures of verbal comprehension, 
perceptual organization, working memory, visual memory, auditory memory, WCST, Trails-
A, CPT, word fluency; No change on Stroop and Trails-B. 
Stirling et al. (2003)(13) 24 FE patients 10.6 years Decline in performance on three out of nine tests: object assembly, picture completion, 
and memory for design. Stable performance on measures of executive/frontal function. 
Hill et al. (2004)(14) 45 FE patients 
33 healthy controls 
1-2 years No change in executive functions, motor skills; Less improvement than controls in 
attention and verbal memory; Improvement in visual memory and visual perception 
compared to controls.  
Hoff et al. (2005)(15) 21 FE patients 
8 healthy controls 
10 years High stability on most neuropsychological tests; Improvement in Verbal IQ, Stroop Color 
Word and Finger Tapping in both patients and controls; Greater improvement in patients 
compared to controls in Visual Reproduction-Immediate. 
sTable 1. Cont. 
Study N (Subjects) Length of 
follow-up 
Summary of findings 
Addington et al. 
(2005)(16) 
105 FE patients 
66 healthy controls 
Patients: 
1,2 and 3 
years HC: 1 
year 
Improvement in patients over three years in several tests, but failure to improve during 
the first year on verbal fluency, visual memory, trails A and the Stroop, compared to 
controls who did improve. Controls failed to improve on the RAVLT, letter-number, WCST 
and Pegboard-dominant. 
Albus et al. (2006)(17) 71 FE patients 
71 healthy controls 
5 years Both groups showed stability or improvement in the majority of cognitive domains. 
Patients showed deterioration in verbal fluency while controls improved, as well as a 
trend towards less improvement in semantic memory and retention rate compared to 
controls.  
Keefe et al. (2006)(18) 58 and 26 FE patients  1 and 2 
years 
Improvement in attention, processing speed, verbal memory and working memory. 
Kopala et al. (2006)(19) 20 FE patients 2 years Improvement on measures of verbal learning, verbal fluency, attention, and executive 
function. 
Keefe et al. (2007)(20) 81 FE patients 1 year Improvement across neuropsychological tests. 
Rund et al. (2007)(21) 138 FE patients (1 year) 
111 FE patients (2 years) 
1 and 2 
years 
Improvement in working memory and verbal learning dimensions.  
Rodriguez-Sanchez et al. 
(2008)(22) 
112 FE patients  
22 healthy controls 
1 year Equivalent improvement in patients and controls in all cognitive domains, except verbal 
memory where controls showed greater improvement than controls. 
Mayoral et al. (2008)(23) 22 FE patients 
29 healthy controls 
2 years Patients and controls showed improvement in global cognitive performance and 
attention, and no change in working memory. Patients, but not controls showed 
improvement in learning and memory, and no change in executive function. Controls, but 
not patients, showed improvement in executive function, and no change in learning and 
memory. 
Zipparo et al. (2008)(24) 32 FE patients 2-3 years Stability on the majority of cognitive tests; Improvement in full-scale and performance IQ, 
and visual memory; A trend towards decline in verbal knowledge, attention and 
visuospatial ability. 
Crespo-Facorro et al. 
(2009)(25) 
104 FE patients 
37 healthy controls 
1 year Patients, but not controls, showed improvement on measures of motor speed, executive 
function and long-term recall; Similar improvement in patients and controls on all other 
cognitive measures.   
Leeson et al. (2009)(26) 104 FE patients  
25 healthy controls 
1 and 3 
years 
Patients showed deterioration in attentional set shifting task performance from baseline 
to 1 year, but no difference between baseline and 3 or 6 years; Controls showed no 
change over time. 31 FE patients  6 years 
de Mello Ayres et al. 
(2010)(27) 
56 FE patients 





Similar improvement on digit span forward, digit span backward, and verbal fluency in 
patients and controls. 
 
sTable 1. Cont. 
Study N (Subjects) Length of 
follow-up 
Summary of findings 
Popolo et al. (2010)(28) 15 FE patients 1 year No significant change over time.  
Leeson et al. (2011)(29) 78 FE patients 
27 healthy controls 
1 year Patients with normal IQ at baseline showed similar IQ improvement as controls; patients 
with low IQ at baseline showed less improvement than other patients and controls; All 
patients showed similar improvement in memory and executive function as controls. 60 FE patients  
27 healthy controls 
3 years 
Liu et al. (2011)(30) 31 FE patients 1 and 3 
years 
Stability and improvement on measures of executive function. 
Barder et al. (2012)(31)  62 FE patients 1, 2 and 5 
years 
Improvement in working memory and impulsivity in the first two years, followed by no 
change over the next three years; Decrease in motor speed from 2 to 5 years; No change 
in verbal learning and executive function. 
Ayesa-Arriola et al. 
(2013)(32) 
79 FE patients 
41 healthy controls 
3 years Patients and controls showed improvement in most cognitive scores; Less improvement in 
patients compared to controls on measures of verbal memory and processing speed. 
Rodríguez-Sánchez et al. 
(2013)(33) 
155 FE patients 
43 healthy controls 
3 years Increasing deviation of patients from controls in measures of verbal and visual memory; 
Similar improvement in patients and controls on measures of motor dexterity and 
attention. 
Chang et al. (2014)(34) 93 FE patients 1, 2 and 3 
years 
Improvement in measures of working memory, logical memory, visual reproduction and 
WCST; No change in category fluency. 
Rund et al. (2015)(35) 167 FE patients (1 year) 
159 FE patients (2 years) 
101 FE patients (5 years) 
114 FE patients (10 years) 
1, 2, 5 and 
10 years 
Stability in composite score of neurocognitive function over time. 
Amoretti et al. (2016)(36) 45 FE patients 
41 healthy controls 
2 years Improvement in verbal memory and attention; measures of working memory and 
executive function remained stable. 
Bergh et al. (2016)(37) 171 FE patients 5 and 10 
years 
Performance on cognitive tests (of executive function) did not change significantly over 
time. 
Kenney et al. (2016)(38) 23 FE patients 
21 healthy controls 
4 years Patients showed less improvement than controls on measures of processing speed and 
verbal learning; there were no group difference in change on the remaining cognitive 
metrics. 
Labad et al. (2016)(39) 36 FE patients 1 year Performance on cognitive tests (of processing speed, attention, working memory, 
verbal/visual learning and reasoning) did not change significantly over time. 
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